Zusammenfassung
Studienziel
Die aktuelle Studie untersucht die Einstel-lung zu antidepressiver Therapie der Allgemeinbevöl-kerung.
Methoden
Es wurden 234 ProbandInnen (139 Frauen und 95 Männer) mittels persönlich vorgelegten Fragebögen (Dauer 15–20 min) zu soziodemographischen, psychoedukativen Elementen und der persönlichen Einstellung befragt, sowie die Stigmatisierungsgrade mittels „Revised Perceived Devaluation Discrimination Scale“/„Revised Internalized Stigma of Mental Illness Scale“/„Attitudes Toward Mental Health Treatment“-Scale erfasst.
Ergebnisse
65 Personen (27,8 %) gaben an, ein- oder mehrmals an einer depressiven Episode gelitten zu haben, die restlichen 169 Personen (72,2 %) gaben keinerlei depressive Beschwerden an. Die häufigst assoziierten Wörter mit dem Terminus „Depression“ waren „Krankheit“ und „Angst“. ProbandInnen sahen vor allem bei einsamen Menschen und jenen mit fehlender sozialer Unterstützung ein erhöhtes Risiko für eine Depressionsentwicklung. Es wurde deutlich, dass Menschen mit Depressionen vermehrt „empfundene Stigmatisierung“ erleben, wenn es um ein öffentliches Bekennen zur Einnahme von Antidepressiva geht, obwohl das Ausmaß an „entgegengebrachter Stigmatisierung“ von außen nicht so hoch war und es demnach nicht erklären würde. Depressive Personen gaben im Gegensatz zu jenen ProbandInnen, die keinen depressiven Episoden angaben, an, dass eine medikamentöse Therapie bei Notwendigkeit als hilfreich angesehen wird. Stigmatisierung ist nach wie vor sowohl unter nicht-depressiven Menschen, als auch Menschen mit depressiven Symptomen zu finden und bedarf daher wichtiger Entstigmatisierungsarbeit.
Summary
Objective
The current study investigates the attitude towards antidepressant treatment among general public.
Methods
A total of 234 probands (139 women and 95 men) were asked to complete individually provided questionnaires examining socio-demographic data, psychoeducational levels, as well as personal beliefs concerning antidepressant treatment and levels of present stigmatisation. Three scales were used to quantify stigmatisation levels—“Revised Perceived Devaluation Discrimination Scale”/“Revised Internalized Stigma of Mental Illness Scale”/“Attitudes Toward Mental Health Treatment Scale”, “Revised Perceived Devaluation Discrimination Scale”.
Results
65 people (27.8 %) reported to have had one or more episodes of depression during their lifetime; 169 people (72.2 %) indicated to have never had any episode of that type before. The words “sickness” and “anxiety” were the terms primarily associated with the word “depression”. It was a common belief among interviewees that lonely individuals or those not receiving social support have a higher risk of becoming depressed. We further found that people experience higher levels of internalized stigma when talking about their antidepressant drug-therapy, than the level of perceived stigma would suggest. Opposed to those not indicating depression depressed people indicated that they considered the use of antidepressant medication helpful and a good option, if necessary. Stigma can still be found among those not indicating depression as well as among those with symptoms of depression. Based on the current study we conclude that work in the field of destigmatisation is of great importance.
Literatur
Organization, W.H. Prevention and promotion in mental health. 2002. http://www.who.int/mental_health/media/en/545.pdf.
Meise U, Fleischhacker WW, Schöny W. Es ist leichter ein Atom zu zerstören, als ein Vorurteil. Neuropsychiatrie. 2002;16(1–2):1–4.
Reavley NJ, et al. Stigmatising attitudes towards people with mental disorders: a comparison of Australian health professionals with the general community. Aust N Z J Psychiatry. 2014;48(5):433–41.
Griffiths KM, et al. Stigma in response to mental disorders: a comparison of Australia and Japan. BMC Psychiatry. 2006;6:21.
Reavley NJ, Jorm AF. Young people’s stigmatizing attitudes towards people with mental disorders: findings from an Australian national survey. Aust N Z J Psychiatry. 2011;45(12):1033–9.
Barney LJ, et al. Stigma about depression and its impact on help-seeking intentions. Aust N Z J Psychiatry. 2006;40(1):51–4.
Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14(9):569–80.
Struening EL, et al. Stigma as a barrier to recovery: the extent to which caregivers believe most people devalue consumers and their families. Psychiatr Serv. 2001;52(12):1633–8.
Faller H, Lang H. Medizinische Psychologie und Soziologie. Springer Verlag. 2006. S. 9.
Kasper S, Lehofer M. Depression – medikamentöse Therapie. Clinicum Neuropsy, Sonderausgabe Nov. 2012. S. 3–6.
WHO. Adherence to long term therapies: evidence for action. 2003. http://www.who.int/chp/knowledge/publications/adherence_Section1.pdf.
Fawzi W. et al. Beliefs about medications predict adherence to antidepressants in older adults. Int Psychogeriatr. 2012;24(1):159–69.
Sansone RA, Sansone LA. Antidepressant adherence: are patients taking their medications? Innov Clin Neurosci. 2012;9(5–6):41–6.
Acosta F, Rodriguez L, Cabrera B. Beliefs about depression and its treatments: associated variables and the influence of beliefs on adherence to treatment. Rev Psiquiatr Salud Ment. 2013;6(2):86–92.
Katon W, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry. 1999;56(12):1109–15.
Unutzer J, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288(22):2836–45.
Vergouwen AC, et al. Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry. 2003;64(12):1415–20.
Von Korff M, et al. Effect on disability outcomes of a depression relapse prevention program. Psychosom Med. 2003;65(6):938–43.
Muzina DJ, et al. Rate of non-adherence prior to upward dose titration in previously stable antidepressant users. J Affect Disord. 2011;130(1–2):46–52.
van Dijk L, et al. Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Serv Res. 2007;7:51.
Olfson M, et al. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163(1):101–8.
Shigemura J, et al. Predictors of antidepressant adherence: results of a Japanese Internet-based survey. Psychiatry Clin Neurosci. 2010;64(2):179–86.
Barney LJ, et al. Exploring the nature of stigmatising beliefs about depression and help-seeking: implications for reducing stigma. BMC Public Health. 2009;9:61.
Griffiths KM, Christensen H, Jorm AF. Predictors of depression stigma. BMC Psychiatry. 2008;8:25.
Czyz EK, et al. Self-reported barriers to professional help seeking among college students at elevated risk for suicide. J Am Coll Health. 2013;61(7):398–406.
Yap MB, Reavley NJ, Jorm AF. Associations between stigma and help-seeking intentions and beliefs: findings from an Australian national survey of young people. Psychiatry Res. 2013;210(3):1154–60.
Brown C, et al. Depression stigma, race, and treatment seeking behavior and attitudes. J Community Psychol. 2010:38(3):350–368.
Aikens JE, Nease DE Jr, Klinkman MS. Explaining patients’ beliefs about the necessity and harmfulness of antidepressants. Ann Fam Med. 2008;6(1):23–9.
Aromaa E, et al. Personal stigma and use of mental health services among people with depression in a general population in Finland. BMC Psychiatry. 2011;11:52.
Akhtar-Danesh N, Landeen J. Relation between depression and sociodemographic factors. Int J Ment Health Syst. 2007;1(1):4.
Taqui AM, et al. Depression in the elderly: does family system play a role? A cross-sectional study. BMC Psychiatry. 2007;7:57.
Givens JL, et al. Older patients’ aversion to antidepressants. A qualitative study. J Gen Intern Med. 2006;21(2):146–51.
Maidment R, Livingston G, Katona C. Just keep taking the tablets: adherence to antidepressant treatment in older people in primary care. Int J Geriatr Psychiatry. 2002;17(8):752–7.
Cook TM, Wang J. Descriptive epidemiology of stigma against depression in a general population sample in Alberta. BMC Psychiatry. 2010;10:29.
Sozialversicherungsträger, H.d.ö. Psychische Erkrankungen: Hohe Wachstumsdynamik in Österreich. 2011. http://www.hauptverband.at/portal27/portal/hvbportal/channel_content/cmsWindow?p_pubid=648931&action=2&p_menuid=58215&p_tabid=10.
Interessenkonflikt
Romina Koller, Helmuth Haslacher, Klemens Kienesberger, Michaela Schmöger und Alexandra Schosser deklarieren, dass sie keinen „conflict of interest“ haben.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koller, R., Haslacher, H., Kienesberger, K. et al. Einstellung zu antidepressiver Therapie: Akzeptanz vs. Stigmatisierung. Neuropsychiatr 29, 14–22 (2015). https://doi.org/10.1007/s40211-014-0134-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40211-014-0134-6